Psoriatic Arthritis Market - By Product Type (Prescription & Over the Counter (OTC)), By Drug Class (Non-steroidal Anti-inflammatory Drugs (NSAIDs), Biologics, Disease-modifying Antirheumatic Drugs (DMARDs), & Others), By Route of Administration (Oral, Topical, & Injectable), By Geography - Global Opportunity Analysis & Industry Forecast, 2024 - 2030

Report Code: HCR 70167 Report Format: PDF + Excel

Psoriatic Arthritis Market Overview

Psoriatic Arthritis Market size is projected to reach $13.8 billion by 2026, growing at a CAGR of 7.4% during the forecast period 2021-2026. Psoriatic arthritis is a condition that combines the swollen joints of arthritis with psoriasis and causes red patches of skin topped with silvery scales. It is characterized by a form of inflammation of psoriasis and joints. In the absence of proper treatment, psoriatic arthritis leads to irreversible joint damage. Increase in the demand for magnetic resonance imaging technology for the treatment of psoriatic arthritis, rise in the adoption of enzyme inhibitors and interleukin inhibitors in developed nations, presence of strong pipeline of drugs, growing demand for immunosuppressant drugs, and increase in the research and development activities are the factors that are set to drive the growth of the Psoriatic Arthritis Market for the period 2021-2026.
Psoriatic Arthritis Market

Report Coverage

The report: “Psoriatic Arthritis Market Forecast (2021-2026)”, by Industry ARC, covers an in-depth analysis of the following segments of the Psoriatic Arthritis Market.

By Product Type: Prescription and Over the Counter (OTC).
By Drug Class: Non-steroidal Anti-inflammatory Drugs (NSAIDs), Biologics, Disease-modifying Antirheumatic Drugs (DMARDs), and Others.
By Route of Administration: Oral, Topical, and Injectable.
By Geography: North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, and Rest of South America) and Rest of World (Middle East and Africa).

Key Takeaways

  • Geographically, North America Psoriatic Arthritis Market accounted for the highest revenue share in 2020 and it is poised to dominate over the period 2021-2026 owing to the growing adoption of enzyme inhibitors and interleukin inhibitors for the treatment of psoriatic arthritis.
  • The rise in the demand for biological immunosuppressant drugs in developing nations is driving the biologics segment.
  • The high cost of treatment is one of the major factors that is said to reduce the growth of the Psoriatic Arthritis Market.
  • Detailed analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Psoriatic Arthritis Market report.

Psoriatic Arthritis Market Segment Analysis-By Drug Class

The Psoriatic Arthritis Market based on the Drug Class can be further segmented into the Non-steroidal anti-inflammatory drugs (NSAIDs), Biologics, Disease-modifying Antirheumatic Drugs (DMARDs), and Others. The Biologics segment held the largest share in 2020 and is also estimated to be the fastest growing segment with a CAGR of 8.1% over the period 2021-2026. This growth is owing to the factors such as rise in the demand for immunosuppressant drugs, strong commercial performances of already existing products, and increase in the launches of promising pipeline candidates. Biologics are very target-specific and have less toxicity, which is driving the growth of the Psoriatic Arthritis Market. The Disease-modifying Antirheumatic Drugs (DMARDs) segment held the second largest share in 2020 owing to its ability to control symptoms and minimize joint damage and stave off future complications. DMARDs are maintaining their presence on account of the first-line of treatment and applicability of corticosteroids.

Psoriatic Arthritis Market Segment Analysis-By Route of Administration

The Psoriatic Arthritis Market based on the Route of Administration can be further segmented into the Oral, Topical, and Injectable. The Injectable segment held the largest share in 2020 and is also estimated to be the fastest growing segment with a CAGR of 7.9% over the period 2021-2026. This growth is owing to the factors such as rise in the product launches of biologics and biosimilars and increase in the adoption through subcutaneous or intravenous routes for injecting biosimilars. It allows for greater tolerance of the drug product components with blood components. The growing demand for magnetic resonance imaging-guided injections is driving the growth of the Psoriatic Arthritis Market. The Oral segment held the second largest share in 2020 owing to factors such as safety, good patient compliance, ease of ingestion, and ability to accommodate various types of drugs.

Psoriatic Arthritis Market: Market Share (%) By Route of Administration, 2020
Psoriatic Arthritis Market
For More Details on This Report - Request for Sample

Psoriatic Arthritis Market Segment Analysis-By Geography

North America held the largest share with 33% of the overall market in 2020. The growth in this segment is owing to the factors such as increase in the prevalence of obesity, rise in the adoption of magnetic resonance imaging technology for the treatment of psoriatic arthritis, and growing expenditure on psoriatic arthritis therapeutics. The rise in the adoption of enzyme inhibitors and interleukin inhibitors for the treatment of psoriatic arthritis is driving the growth of the Psoriatic Arthritis Market. Asia-Pacific is estimated to be the fastest growing segment over the period 2021-2026. The growth in this segment is owing to the factors such as rise in the demand for immunosuppressant drugs, growing focus on improving the reimbursement policies, and increasing demand for innovative medicines with improved safety and efficacy profiles.

Psoriatic Arthritis Market Drivers

Presence of Strong Pipeline of Drugs.

The medications showing effectiveness against the cases of psoriatic arthritis are increasingly being adopted across the world. Key players in developed nations are also focusing on enhancing the penetration of innovative immunosuppressant drugs for the treatment of psoriatic arthritis, which is one of the major factors that is driving the growth of the Psoriatic Arthritis Market.

Increase in the Research and Development Activities.

The rise in the research and development activities by the key players has resulted in an increase in the development of biosimilar drugs with enhanced effectiveness. The rapid increase in the prevalence of psoriatic arthritis has further propelled the demand for research activities, which is propelling the growth of the Psoriatic Arthritis Market.

Psoriatic Arthritis Market Challenges

High Cost of Treatment

Economically weak regions with low expenditure on healthcare are posing a threat to the penetration of these products in the markets. The high cost of these immunosuppressant drugs is making them unaffordable to the population in these regions and resulting in delay in diagnosis and gaps in clinical management, which one of the major factors that is estimated to reduce the growth of the Psoriatic Arthritis Market.

Psoriatic Arthritis Market Landscape:

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Psoriatic Arthritis Market. Key companies of this market are Amgen Inc, AbbVie Inc, Bristol-Myers Squibb Company, Johnson & Johnson Services Inc, Celgene Corporation, Eli Lilly and Company, Novartis International AG, Pfizer Inc, UCB S.A., and AstraZeneca plc among others.

Acquisitions/Product Launches:

  • In January 2020, UCB Company has launched CIMZIA® (certolizumab pegol) to treat plaque psoriasis, psoriatic arthritis, pustular psoriasis, and psoriatic erythroderma to provide Japanese psoriatic arthritis patients with a highly effective new biologic option that provides durable disease control.
  • In August 2019, Amgen Inc has acquired Otezla (apremilast), which is the oral and non-biologic treatment for psoriasis and psoriatic arthritis. This acquisition provides an opportunity to strengthen presence in inflammation and continue geographic expansion.

Related Reports

Report Code: HCR 27386

Report Code: HCR 0100

For more Lifesciences and Healthcare Market reports, Please click here
1. Psoriatic Arthritis Market - Overview
    1.1 Definitions and Scope
2. Psoriatic Arthritis Market - Executive Summary
    2.1 Market Revenue and Key Trends by Company
    2.2 Key trends by Product Type
    2.3 Key trends by Route of Administration
    2.4 Key trends by Geography
3.  Psoriatic Arthritis Market – Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Market Value Split by Key Companies
    3.4 Patent Analysis – Key Companies
    3.5 Pricing Analysis
4. Psoriatic Arthritis Market - Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Psoriatic Arthritis Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Psoriatic Arthritis Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Psoriatic Arthritis Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Psoriatic Arthritis Market – By Product Type(Market Size –$Million/$Billion)
    8.1 Prescription
    8.2  Over the Counter (OTC)
9. Psoriatic Arthritis Market – By Drug Class(Market Size –$Million/$Billion)
    9.1 Non-steroidal Anti-inflammatory Drugs (NSAIDs)
    9.2 Biologics
    9.3 Disease-modifying Antirheumatic Drugs (DMARDs)
    9.4 Others
10. Psoriatic Arthritis Market – By Route of Administration(Market Size –$Million/$Billion)
    10.1 Oral
    10.2 Topical
    10.3 Injectable
11. Psoriatic Arthritis Market - By Geography(Market Size –$Million/$Billion)
    11.1 North America
        11.1.1 U.S.
        11.1.2 Mexico
        11.1.3 Canada
    11.2 Europe
        11.2.1 U.K.
        11.2.2 France
        11.2.3 Germany
        11.2.4 Italy
        11.2.5 Spain
        11.2.6 Russia
        11.2.7 Rest of Europe
    11.3 Asia Pacific
        11.3.1 China
        11.3.2 India
        11.3.3 Japan
        11.3.4 South Korea
        11.3.5 Australia & New Zealand
        11.3.6 Rest of APAC
    11.4 South America
        11.4.1 Brazil
        11.4.2 Argentina
        11.4.3 Rest of South America
    11.5 Rest of the World
        11.5.1 Middle East
        11.5.2 Africa
12. Psoriatic Arthritis Market - Entropy
13. Psoriatic Arthritis Market – Industry/Segment Competition Landscape Premium
    13.1 Market Share Analysis
        13.1.1 Global Market Share – Key Companies
        13.1.2 Market Share by Region – Key companies
        13.1.3 Market Share by Countries – Key Companies
        13.1.4 Best Practices for Companies
14. Psoriatic Arthritis Market – Key Company List by Country Premium Premium
15. Psoriatic Arthritis Market Company Analysis
    15.1 Company 1
    15.2 Company 2
    15.3 Company 3
    15.4 Company 4
    15.5 Company 5
    15.6 Company 6
    15.7 Company 7
    15.8 Company 8
    15.9 Company 9
    15.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.

LIST OF TABLES

1.Global Competition Analysis Market 2023-2030 ($M)
2.Global Psoriatic Arthritis Treatment Market Analysis and Forecast , By Product Type Market 2023-2030 ($M)
2.1 By Product Type, Market 2023-2030 ($M) - Global Industry Research
2.1.1 Nonsteriodal Anti-inflammatory Drugs Market 2023-2030 ($M)
2.1.2 Disease Modifying Antirheumatic Drugs Market 2023-2030 ($M)
2.1.3 Biologics Market 2023-2030 ($M)
2.2 By Product Type, Market 2023-2030 ($M) - Global Industry Research
3.Global Psoriatic Arthritis Treatment Market Analysis and Forecast , By Route of Administration Market 2023-2030 ($M)
3.1 By Product Type, Market 2023-2030 ($M) - Global Industry Research
3.1.1 Oral Market 2023-2030 ($M)
3.1.2 Injectable Market 2023-2030 ($M)
3.2 By Product Type, Market 2023-2030 ($M) - Global Industry Research
4.Global Psoriatic Arthritis Treatment Market Analysis and Forecast , By Distribution Channel Market 2023-2030 ($M)
4.1 By Distribution Channel, Market 2023-2030 ($M) - Global Industry Research
4.1.1 Hospital Pharmacies Market 2023-2030 ($M)
4.1.2 Retail Pharmacies Market 2023-2030 ($M)
4.1.3 Mail Order Pharmacies Market 2023-2030 ($M)
4.2 By Distribution Channel, Market 2023-2030 ($M) - Global Industry Research
5.Global Competition Analysis Market 2023-2030 (Volume/Units)
6.Global Psoriatic Arthritis Treatment Market Analysis and Forecast , By Product Type Market 2023-2030 (Volume/Units)
6.1 By Product Type, Market 2023-2030 (Volume/Units) - Global Industry Research
6.1.1 Nonsteriodal Anti-inflammatory Drugs Market 2023-2030 (Volume/Units)
6.1.2 Disease Modifying Antirheumatic Drugs Market 2023-2030 (Volume/Units)
6.1.3 Biologics Market 2023-2030 (Volume/Units)
6.2 By Product Type, Market 2023-2030 (Volume/Units) - Global Industry Research
7.Global Psoriatic Arthritis Treatment Market Analysis and Forecast , By Route of Administration Market 2023-2030 (Volume/Units)
7.1 By Product Type, Market 2023-2030 (Volume/Units) - Global Industry Research
7.1.1 Oral Market 2023-2030 (Volume/Units)
7.1.2 Injectable Market 2023-2030 (Volume/Units)
7.2 By Product Type, Market 2023-2030 (Volume/Units) - Global Industry Research
8.Global Psoriatic Arthritis Treatment Market Analysis and Forecast , By Distribution Channel Market 2023-2030 (Volume/Units)
8.1 By Distribution Channel, Market 2023-2030 (Volume/Units) - Global Industry Research
8.1.1 Hospital Pharmacies Market 2023-2030 (Volume/Units)
8.1.2 Retail Pharmacies Market 2023-2030 (Volume/Units)
8.1.3 Mail Order Pharmacies Market 2023-2030 (Volume/Units)
8.2 By Distribution Channel, Market 2023-2030 (Volume/Units) - Global Industry Research
9.North America Competition Analysis Market 2023-2030 ($M)
10.North America Psoriatic Arthritis Treatment Market Analysis and Forecast , By Product Type Market 2023-2030 ($M)
10.1 By Product Type, Market 2023-2030 ($M) - Regional Industry Research
10.1.1 Nonsteriodal Anti-inflammatory Drugs Market 2023-2030 ($M)
10.1.2 Disease Modifying Antirheumatic Drugs Market 2023-2030 ($M)
10.1.3 Biologics Market 2023-2030 ($M)
10.2 By Product Type, Market 2023-2030 ($M) - Regional Industry Research
11.North America Psoriatic Arthritis Treatment Market Analysis and Forecast , By Route of Administration Market 2023-2030 ($M)
11.1 By Product Type, Market 2023-2030 ($M) - Regional Industry Research
11.1.1 Oral Market 2023-2030 ($M)
11.1.2 Injectable Market 2023-2030 ($M)
11.2 By Product Type, Market 2023-2030 ($M) - Regional Industry Research
12.North America Psoriatic Arthritis Treatment Market Analysis and Forecast , By Distribution Channel Market 2023-2030 ($M)
12.1 By Distribution Channel, Market 2023-2030 ($M) - Regional Industry Research
12.1.1 Hospital Pharmacies Market 2023-2030 ($M)
12.1.2 Retail Pharmacies Market 2023-2030 ($M)
12.1.3 Mail Order Pharmacies Market 2023-2030 ($M)
12.2 By Distribution Channel, Market 2023-2030 ($M) - Regional Industry Research
13.South America Competition Analysis Market 2023-2030 ($M)
14.South America Psoriatic Arthritis Treatment Market Analysis and Forecast , By Product Type Market 2023-2030 ($M)
14.1 By Product Type, Market 2023-2030 ($M) - Regional Industry Research
14.1.1 Nonsteriodal Anti-inflammatory Drugs Market 2023-2030 ($M)
14.1.2 Disease Modifying Antirheumatic Drugs Market 2023-2030 ($M)
14.1.3 Biologics Market 2023-2030 ($M)
14.2 By Product Type, Market 2023-2030 ($M) - Regional Industry Research
15.South America Psoriatic Arthritis Treatment Market Analysis and Forecast , By Route of Administration Market 2023-2030 ($M)
15.1 By Product Type, Market 2023-2030 ($M) - Regional Industry Research
15.1.1 Oral Market 2023-2030 ($M)
15.1.2 Injectable Market 2023-2030 ($M)
15.2 By Product Type, Market 2023-2030 ($M) - Regional Industry Research
16.South America Psoriatic Arthritis Treatment Market Analysis and Forecast , By Distribution Channel Market 2023-2030 ($M)
16.1 By Distribution Channel, Market 2023-2030 ($M) - Regional Industry Research
16.1.1 Hospital Pharmacies Market 2023-2030 ($M)
16.1.2 Retail Pharmacies Market 2023-2030 ($M)
16.1.3 Mail Order Pharmacies Market 2023-2030 ($M)
16.2 By Distribution Channel, Market 2023-2030 ($M) - Regional Industry Research
17.Europe Competition Analysis Market 2023-2030 ($M)
18.Europe Psoriatic Arthritis Treatment Market Analysis and Forecast , By Product Type Market 2023-2030 ($M)
18.1 By Product Type, Market 2023-2030 ($M) - Regional Industry Research
18.1.1 Nonsteriodal Anti-inflammatory Drugs Market 2023-2030 ($M)
18.1.2 Disease Modifying Antirheumatic Drugs Market 2023-2030 ($M)
18.1.3 Biologics Market 2023-2030 ($M)
18.2 By Product Type, Market 2023-2030 ($M) - Regional Industry Research
19.Europe Psoriatic Arthritis Treatment Market Analysis and Forecast , By Route of Administration Market 2023-2030 ($M)
19.1 By Product Type, Market 2023-2030 ($M) - Regional Industry Research
19.1.1 Oral Market 2023-2030 ($M)
19.1.2 Injectable Market 2023-2030 ($M)
19.2 By Product Type, Market 2023-2030 ($M) - Regional Industry Research
20.Europe Psoriatic Arthritis Treatment Market Analysis and Forecast , By Distribution Channel Market 2023-2030 ($M)
20.1 By Distribution Channel, Market 2023-2030 ($M) - Regional Industry Research
20.1.1 Hospital Pharmacies Market 2023-2030 ($M)
20.1.2 Retail Pharmacies Market 2023-2030 ($M)
20.1.3 Mail Order Pharmacies Market 2023-2030 ($M)
20.2 By Distribution Channel, Market 2023-2030 ($M) - Regional Industry Research
21.APAC Competition Analysis Market 2023-2030 ($M)
22.APAC Psoriatic Arthritis Treatment Market Analysis and Forecast , By Product Type Market 2023-2030 ($M)
22.1 By Product Type, Market 2023-2030 ($M) - Regional Industry Research
22.1.1 Nonsteriodal Anti-inflammatory Drugs Market 2023-2030 ($M)
22.1.2 Disease Modifying Antirheumatic Drugs Market 2023-2030 ($M)
22.1.3 Biologics Market 2023-2030 ($M)
22.2 By Product Type, Market 2023-2030 ($M) - Regional Industry Research
23.APAC Psoriatic Arthritis Treatment Market Analysis and Forecast , By Route of Administration Market 2023-2030 ($M)
23.1 By Product Type, Market 2023-2030 ($M) - Regional Industry Research
23.1.1 Oral Market 2023-2030 ($M)
23.1.2 Injectable Market 2023-2030 ($M)
23.2 By Product Type, Market 2023-2030 ($M) - Regional Industry Research
24.APAC Psoriatic Arthritis Treatment Market Analysis and Forecast , By Distribution Channel Market 2023-2030 ($M)
24.1 By Distribution Channel, Market 2023-2030 ($M) - Regional Industry Research
24.1.1 Hospital Pharmacies Market 2023-2030 ($M)
24.1.2 Retail Pharmacies Market 2023-2030 ($M)
24.1.3 Mail Order Pharmacies Market 2023-2030 ($M)
24.2 By Distribution Channel, Market 2023-2030 ($M) - Regional Industry Research
25.MENA Competition Analysis Market 2023-2030 ($M)
26.MENA Psoriatic Arthritis Treatment Market Analysis and Forecast , By Product Type Market 2023-2030 ($M)
26.1 By Product Type, Market 2023-2030 ($M) - Regional Industry Research
26.1.1 Nonsteriodal Anti-inflammatory Drugs Market 2023-2030 ($M)
26.1.2 Disease Modifying Antirheumatic Drugs Market 2023-2030 ($M)
26.1.3 Biologics Market 2023-2030 ($M)
26.2 By Product Type, Market 2023-2030 ($M) - Regional Industry Research
27.MENA Psoriatic Arthritis Treatment Market Analysis and Forecast , By Route of Administration Market 2023-2030 ($M)
27.1 By Product Type, Market 2023-2030 ($M) - Regional Industry Research
27.1.1 Oral Market 2023-2030 ($M)
27.1.2 Injectable Market 2023-2030 ($M)
27.2 By Product Type, Market 2023-2030 ($M) - Regional Industry Research
28.MENA Psoriatic Arthritis Treatment Market Analysis and Forecast , By Distribution Channel Market 2023-2030 ($M)
28.1 By Distribution Channel, Market 2023-2030 ($M) - Regional Industry Research
28.1.1 Hospital Pharmacies Market 2023-2030 ($M)
28.1.2 Retail Pharmacies Market 2023-2030 ($M)
28.1.3 Mail Order Pharmacies Market 2023-2030 ($M)
28.2 By Distribution Channel, Market 2023-2030 ($M) - Regional Industry Research

LIST OF FIGURES

1.US Psoriatic Arthritis Market Revenue, 2023-2030 ($M)
2.Canada Psoriatic Arthritis Market Revenue, 2023-2030 ($M)
3.Mexico Psoriatic Arthritis Market Revenue, 2023-2030 ($M)
4.Brazil Psoriatic Arthritis Market Revenue, 2023-2030 ($M)
5.Argentina Psoriatic Arthritis Market Revenue, 2023-2030 ($M)
6.Peru Psoriatic Arthritis Market Revenue, 2023-2030 ($M)
7.Colombia Psoriatic Arthritis Market Revenue, 2023-2030 ($M)
8.Chile Psoriatic Arthritis Market Revenue, 2023-2030 ($M)
9.Rest of South America Psoriatic Arthritis Market Revenue, 2023-2030 ($M)
10.UK Psoriatic Arthritis Market Revenue, 2023-2030 ($M)
11.Germany Psoriatic Arthritis Market Revenue, 2023-2030 ($M)
12.France Psoriatic Arthritis Market Revenue, 2023-2030 ($M)
13.Italy Psoriatic Arthritis Market Revenue, 2023-2030 ($M)
14.Spain Psoriatic Arthritis Market Revenue, 2023-2030 ($M)
15.Rest of Europe Psoriatic Arthritis Market Revenue, 2023-2030 ($M)
16.China Psoriatic Arthritis Market Revenue, 2023-2030 ($M)
17.India Psoriatic Arthritis Market Revenue, 2023-2030 ($M)
18.Japan Psoriatic Arthritis Market Revenue, 2023-2030 ($M)
19.South Korea Psoriatic Arthritis Market Revenue, 2023-2030 ($M)
20.South Africa Psoriatic Arthritis Market Revenue, 2023-2030 ($M)
21.North America Psoriatic Arthritis By Application
22.South America Psoriatic Arthritis By Application
23.Europe Psoriatic Arthritis By Application
24.APAC Psoriatic Arthritis By Application
25.MENA Psoriatic Arthritis By Application